companydata.dkInnosurge Biologics A/S: Financial statements 2020
CVR: 38768964
Innosurge Biologics A/S (CVR 38768964) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK -695,490 and a net result of DKK -2,600,178 compared with DKK 290,106 the year before. Equity amounted to DKK 1,449,819. The solvency ratio was 47%. The company had 3 employees in the financial year.
- Gross Profit
- -695,490 kr.
- Profit/Loss
- -2,600,178 kr.
- Equity
- 1,449,819 kr.
- Total Assets
- 3,087,776 kr.
- Employees
- 3
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | -695 t. | -2.6 mio. | 1.4 mio. | 3 |
| 2019 | - | 1.2 mio. | 290 t. | 2 mio. | 2 |
| 2018 | - | 1.7 mio. | 799 t. | 1.8 mio. | 1 |
How creditworthy is Innosurge Biologics A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
Innosurge Biologics A/S has published its annual report for 2019. Gross profit came to DKK 1,241,663, and the net result was DKK 290,106.
As of April 20, 2020, Heinz Kvottrup Lorentzen has joined the board of directors of Innosurge Biologics A/S.
As of April 20, 2020, Svend Aage Jensen has left the board of directors of Innosurge Biologics A/S.
As of April 19, 2020, Heinz Kvottrup Lorentzen has left the board of directors of Innosurge Biologics A/S.
About Innosurge Biologics A/S
Innosurge Biologics A/S is a Danish company of the type Aktieselskab based in Randers NV, founded in 2017. The company is registered under the industry Engroshandel med læge- og hospitalsartikler. The management consists of Peter Møller Lassen. The company is owned by CMA HOLDING RANDERS ApS. The company has 1 employee. In 2025, the company reported a gross profit of DKK 4,455,235 and a net result of DKK 1,662,593 compared with DKK 251,617 the year before. Equity amounted to DKK 2,897,096.